OfficeHours

AUGUST 20, 2023

Private equity involves investing capital directly into private businesses that are not publicly traded on stock exchanges (that would be a hedge fund). Once improved, the exit can then take place, usually in the form of another sale or an Initial Public Offering (IPO), both of which are usually under the advice of an investment bank.

Private Equity 130

Private Equity Equities Investment Banking Finance 130

Razorpay

JULY 27, 2023

Investment Banking Services Initial Public Offering (IPO) When a privately-owned business wants to become a publicly traded company, it goes through an IPO , or Initial Public Offering. There are a lot of other ways that investment banks make money, like Asset Managem ent and proprietary trading.

Investment Banking 52

Investment Banking Bank Banking Investment 52

Razorpay

AUGUST 9, 2023

Underwriting Services Merchant banks also provide underwriting services for initial public offerings (IPOs), private placements, follow-on public offerings (FPOs) and rights issues. This service helps companies to raise the required funds from the public.

Bank 52

Bank Banking Business Underwriting 52

Peak Frameworks

OCTOBER 30, 2023

Loan Origination or Service Fees: This is a one-time fee charged by the bank when initiating a new loan, serving as a setup fee for the loan process. Trading and Proprietary Trading Many large banks are involved in trading activities. 2019 was a notable year for trading, especially for banks like J.P.

Bank 52

Bank Banking Proprietary Trading Investment Banking 52

Focus Investment Banking

FEBRUARY 25, 2024

The benefits of going public are significant. First, there’s the ability to raise substantial capital by issuing shares to the public in an initial public offering (IPO), as well as secondary offerings. For more information, contact him at michael.mcgregor@focusbankers.com.

Private Equity 52

Private Equity IPO Equities Public Trading 52

Cooley M&A

JANUARY 23, 2024

For example, in the biopharma space, AbbVie, Bristol Myers Squibb, AstraZeneca, and Roche each announced multiple big-ticket acquisitions in the fourth quarter – including Abbvie’s acquisition of ImmunoGen for $10.1 billion; Bristol Myer Squibb’s acquisition of RayzeBio for $4.1 billion and Cerevel Therapeutics for $8.7

M&A 52

M&A Mergers and Acquisitions Acquisitions Pharmaceutical 52

Deal Law Wire

FEBRUARY 9, 2021

This increase can be at least partly attributed to the development of 0% commission trading mobile applications as well as the extra time retail investors have to develop their own personal trading strategies due to COVID-19 social restrictions. Private Companies. Conclusion.

Retail 40

Retail Investors M&A Negotiation 40

Cooley M&A

MARCH 1, 2019

These include prevailing market sentiment, current appetite for acquisitions in a particular sector and the political and economic environment, all of which can change well within a given transaction timetable. The intended post-transaction ownership will also affect how the offering is structured and its viability.

IPO 52

IPO Valuation M&A Business 52

Cooley M&A

JANUARY 25, 2023

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

SEPTEMBER 16, 2022

The rise of founder-led, venture capital-backed companies in recent years has coincided with a surge of companies implementing dual-class share structures in connection with their initial public offerings. Voting agreements in public M&A transactions. Stockholder litigation. As always, ambiguity begets litigation.

M&A 59

M&A IPO Shares Mergers and Acquisitions 59

Cooley M&A

MARCH 22, 2023

With the US initial public offering markets continuing to remain largely closed, and special purpose acquisition company combinations being costly and complex, there’s a new kid in town for foreign companies looking to go public in the US: reverse mergers. While the U.S.

Mergers 52

Mergers IT Mergers and Acquisitions IPO 52

Cooley M&A

JANUARY 30, 2024

Software companies with a target on their backs Public software companies (particularly those with mature revenue growth rates) are often ripe acquisition targets for mega cap tech and highly acquisitive, software focused private equity sponsors, and therefore present easy targets for “sell the company” campaigns by activists.

Private Equity 52

Private Equity M&A Capital Investors 52

Cooley M&A

JANUARY 25, 2023

The year started off with a bang, with mega-deals such as Microsoft’s pending $69 billion acquisition of Activision Blizzard, Elon Musk’s $44 billion acquisition of Twitter and Broadcom’s pending $61 billion acquisition of VMware inked in quick succession. Tech M&A in 2022 was a tale of two halves.

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Cooley M&A

JANUARY 22, 2025

billion acquisition of Alpine Immune; by contrast, there were eight US biotech acquisitions exceeding $5 billion in 2023. 2024 saw companies focusing on internal research and development, innovative partnerships, and targeted bolt-on asset acquisitions to bolster their pipelines. from 2023. [1]

M&A 64

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 64

The New York Times: Mergers, Acquisitions and Dive

APRIL 3, 2024

Michael and Gerald Shvartsman, who had originally pleaded not guilty to securities fraud charges, each pleaded guilty to one count of securities fraud.

Media 142

Media Trading Securities Initial Public Offering 142

The New York Times: Mergers, Acquisitions and Dive

JULY 3, 2023

Digital World’s settlement with the S.E.C. could clear the way for a merger with Trump Media & Technology Group.

Media 84

Media Business Mergers IT 84